ESPR icon

Esperion Therapeutics

142 hedge funds and large institutions have $598M invested in Esperion Therapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 45 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

26% less capital invested

Capital invested by funds: $805M → $598M (-$206M)

30% less call options, than puts

Call options by funds: $14.9M | Put options by funds: $21.3M

42% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 31

Holders
142
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14.9M
Puts
$21.3M
Net Calls
Net Calls Change

Top Buyers

1 +$11.2M
2 +$8.46M
3 +$5.9M
4
Marshall Wace
Marshall Wace
United Kingdom
+$3.01M
5
MG
Meditor Group
Bermuda
+$2.94M

Top Sellers

1 -$18.2M
2 -$10.5M
3 -$7.43M
4
PCM
Pentwater Capital Management
Florida
-$6.73M
5
Axa
Axa
France
-$3.57M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$736K
52
$726K
53
$708K
54
$695K
55
$620K
56
$613K
57
$604K
58
$601K
59
$583K
60
$572K
61
$571K
62
$553K
63
$542K
64
$424K
65
$423K
66
$417K
67
$417K
68
$410K
69
$406K
70
$384K
71
$371K
72
$368K
73
$351K
74
$337K
75
$328K